HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Apheresis Column Treats Dialysis-Related Amyloidosis

By HospiMedica International staff writers
Posted on 18 Mar 2015
Print article
Image: The Lixelle apheresis columns are available in three sizes (Photo courtesy of Kaneka).
Image: The Lixelle apheresis columns are available in three sizes (Photo courtesy of Kaneka).
A new device treats dialysis-related amyloidosis (DRA), a chronic, progressive condition caused by the buildup in the body of a protein called beta 2-microglobulin (B2M).

The Lixelle Beta 2-microglobulin Apheresis Column removes B2M molecules with the aid of porous cellulose beads specifically designed to bind to B2M as the patient’s blood passes over them. The filtration device is used prior to and in conjunction with hemodialysis. The device can help patients who have developed symptoms related to DRA, and may be especially useful for those patients who may not have access to extended dialysis therapies or who may not be eligible for kidney transplant.

The most common adverse events associated with use are temporary hypotension and a decrease in hematocrit, both of which are common adverse events for all patients undergoing dialysis or a similar extracorporeal therapy. The Lixelle Beta 2-microglobulin Apheresis Column is a product of Kaneka (Osaka, Japan), and has been approved by the US Food and Drug Administration (FDA) under the Humanitarian Device Exemption (HDE) pathway.

“While DRA affects only a small population of patients on dialysis, there are not many treatment options for these patients, and some options may not be available to patients in all areas,” said William Maisel, MD, MPH, chief scientist and acting director of the office of device evaluation in the FDA’s Center for Devices and Radiological Health (CDRH). “The Lixelle Beta 2-microglobulin Apheresis Column may provide this patient population with an option for relieving some of the debilitating symptoms of DRA.”

DRA is a complication of kidney failure, especially in people who have been on hemodialysis for more than five years. The buildup of B2M in the blood leads to deposits of the protein form in bones, joints, and tendons, resulting in painful and stiff joints, bone cysts that can lead to bone fractures, and torn tendons and ligaments. B2M deposits can also affect the digestive tract and internal organs such as the heart and lungs.

Related Links:

Kaneka


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
24.5-inch Full HD 2D OLED Medical Monitor
PVM-2551MD

Print article

Channels

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more